Document Detail


Injectable atypical antipsychotics for agitation in borderline personality disorder.
MedLine Citation:
PMID:  16721704     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients.
Authors:
J C Pascual; M Madre; J Soler; J Barrachina; M J Campins; E Alvarez; V Pérez
Related Documents :
12907924 - Methylphenidate-induced obsessive-compulsive symptoms in an elderly man.
665794 - Causes for the premature interruption of psychotherapy by private practice patients.
9538674 - Stiff-man syndrome. results of interviews and psychologic testing.
3069984 - The clinical use of disulfiram (antabuse): a review.
16901564 - D-dimer local expression is increased in symptomatic patients undergoing carotid endart...
12764054 - Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction.
Publication Detail:
Type:  Comparative Study; Letter    
Journal Detail:
Title:  Pharmacopsychiatry     Volume:  39     ISSN:  0176-3679     ISO Abbreviation:  Pharmacopsychiatry     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-05-24     Completed Date:  2006-09-28     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8402938     Medline TA:  Pharmacopsychiatry     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  117-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / administration & dosage*
Benzodiazepines / administration & dosage
Bipolar Disorder / diagnosis,  drug therapy
Borderline Personality Disorder / drug therapy*
Comorbidity
Emergency Services, Psychiatric
Female
Humans
Injections, Intramuscular
Male
Middle Aged
Piperazines / administration & dosage*
Psychiatric Status Rating Scales
Psychomotor Agitation / drug therapy*
Psychotic Disorders / diagnosis,  drug therapy
Schizophrenia / diagnosis,  drug therapy
Thiazoles / administration & dosage*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Piperazines; 0/Thiazoles; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 146939-27-7/ziprasidone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in...
Next Document:  Parental bonding in childhood and psychological symptoms in a sample of adults with intersexuality